Memory Enhancement in Aging With Optimal Dosing
Personalized Memory Enhancement in Aging: Pattern-Optimized tACS With Closed-Loop Precision Modulation
1 other identifier
interventional
240
1 country
1
Brief Summary
This project optimizes high-resolution transcranial Alternating Current Stimulation (tACS) to improve memory in healthy older adults, advancing drug-free approaches for Alzheimer's disease and related dementia (ADRD). We test stimulation schedules and develop an adaptive, brain-guided tACS system to strengthen memory-supporting networks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2026
CompletedFirst Posted
Study publicly available on registry
March 10, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2031
July 22, 2026
July 1, 2026
4.7 years
February 9, 2026
July 21, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Visual working memory capacity measured behaviorally
Behavioral k-capacity estimate derived from the change-detection task
Baseline, 1-week after intervention, 1-month after intervention
Interruption suppression measured behaviorally
Memory accuracy performance difference between interruption and control trials on the interruption working memory task
Baseline, 1-week after intervention, 1-month after intervention
EEG phase locking value (PLV) during working memory retention
Phase locking value between frontotemporal EEG electrodes within the theta frequency band during the memory retention interval of the visual working memory task
Baseline, 1-week after intervention, 1-month after intervention
EEG phase amplitude coupling (PAC) during working memory retention
Theta phase gamma amplitude cross-frequency coupling at temporal EEG electrodes during the memory retention interval of the visual working memory task
Baseline, 1-week after intervention, 1-month after intervention
Study Arms (6)
1-day patterned tACS
EXPERIMENTAL3-day patterned tACS
EXPERIMENTAL5-day patterned tACS
EXPERIMENTAL1-day continuous tACS
EXPERIMENTAL3-day continuous tACS
EXPERIMENTAL5-day continuous tACS
EXPERIMENTALInterventions
Device: High definition transcranial electrical current stimulation Low-intensity, noninvasive application of electrical current to the human scalp with the goal of modulating levels of neuronal excitability.
Device: High definition transcranial electrical current stimulation Low-intensity, noninvasive application of electrical current to the human scalp with the goal of modulating levels of neuronal excitability.
Device: High definition transcranial electrical current stimulation Low-intensity, noninvasive application of electrical current to the human scalp with the goal of modulating levels of neuronal excitability.
Device: High definition transcranial electrical current stimulation Low-intensity, noninvasive application of electrical current to the human scalp with the goal of modulating levels of neuronal excitability.
Device: High definition transcranial electrical current stimulation Low-intensity, noninvasive application of electrical current to the human scalp with the goal of modulating levels of neuronal excitability.
Device: High definition transcranial electrical current stimulation Low-intensity, noninvasive application of electrical current to the human scalp with the goal of modulating levels of neuronal excitability.
Eligibility Criteria
You may qualify if:
- years of age or older
- normal or corrected-to-normal vision
- color vision
You may not qualify if:
- pregnant
- metal implants in head
- implanted electronic devices
- history of neurological problems or head injury
- skin sensitivity
- claustrophobia
- dementia (normal Montreal Cognitive Assessment \> 25)
- depression (normal Geriatric Depression Scale \< 10)
- history of psychosis
- cognitive deficits (MoCA\>25)
- any psychoactive medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
111 Cummington Mall
Boston, Massachusetts, 02215, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Reinhart, PhD
Boston University Charles River Campus
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2026
First Posted
March 10, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
January 31, 2031
Study Completion (Estimated)
January 31, 2031
Last Updated
July 22, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share